Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the obesity drug market. The Danish company announced in a statement on Tuesday that it would use AI to analyze complex datasets, identify promising drug candidates…
Politics
·
Novo Nordisk partners with OpenAI in weight loss drug race
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
Powell, Harding to face off in Nebraska House race to replace Bacon
Democrat Denise Powell is projected to win the Democratic primary for Nebraska’s “blue dot” district Tuesday, according ...
CitrixNews Staff
·
1 hour ago
Politics
Nvidia C.E.O. Jensen Huang Hitches Ride With Trump to China After Last-Minute Invite
Jensen Huang boarded Air Force One in Alaska, joining a delegation of more than a dozen business leaders accompanying Pr...
CitrixNews Staff
·
1 hour ago
Politics
Nebraska secretary of state loses GOP primary
Nebraska Secretary of State Bob Evnen (R) is projected to lose his slot as the state’s top elections official to a prima...
CitrixNews Staff
·
1 hour ago
Politics
‘Operation Epic Furious: Strait to Hell’ video game installed on National Mall
Three free arcade games mocking Operation Epic Fury were installed on the National Mall on Monday by The Secret Handshak...
CitrixNews Staff
·
2 hours ago